Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine.

Br J Ophthalmol · 2025 · PMC12418587 · PMID 40345841

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp<0.001actually significant

Baseline AL was a highly significant predictor of AL progression in both the univariate (β=0.982, p<0.001) and multivariate models (β=1.010, p<0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.